systemic therapy in pd-l1–positive gastric cancer
Published 5 years ago • 156 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
1:25
pd-1 and pd-l1 expression in esophageal and gastric cancer
-
1:06
associations of pd-1 and pd-l1 expression in esophageal and gastric cancer
-
0:31
role of immunotherapy in gastric cancers
-
13:42
systemic therapy for gastric cancer - dr. bushra shariff
-
1:57
pd-l1 as a prognostic factor in gastric cancer patients
-
16:43
2021 international gastric cancer educational symposium - advances in systemic therapy
-
2:20
systemic therapy and future of gej cancer treatment
-
1:06:54
beyond the horizon in gastric cancer: updated evidence on how systemic therapies are redefining care
-
56:48
immunotherapy for gastroesophageal cancer
-
0:54
the role of biomarkers in gastric cancers
-
1:05
dr. svensson on pd-1/pd-l1 status in esophageal and gastric adenocarcinoma
-
35:40
chemotherapy, targeted treatments, and immunotherapy
-
1:00:33
immunotherapy and targeted therapies for gastric cancer patients webinar
-
42:54
gastric cancer: the era of genomics and targeted therapy
-
1:04:49
navigating multidisciplinary care with immunotherapy in esophageal/gej cancer
-
3:52
her2-positive gastric cancer
-
59:06
gastric and gej cancers: treatment planning and sequencing in the era of immunotherapy
-
1:52
dr. chau on findings of ramucirumab plus pembrolizumab in gastric/gej cancer
-
1:22:53
33 first line therapy for her2- pdl1 gea